Literature DB >> 21658000

ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders.

E Anagnostou1, D Mavrogianni, C Theofanakis, P Drakakis, R Bletsa, A Demirol, T Gurgan, A Antsaklis, D Loutradis.   

Abstract

PURPOSE: Previous studies in humans concluded that a multigenic model including specific FSHR, ESR1 and ESR2 genotype patterns may partially explain the poor response to FSH. The aim of our study is to analyse three different loci -polymorphisms in ESR1 Pvu II, ESR2 Rsa I and Ser680Asn FSH receptor gene- in a Greek population and their involvement in stimulation outcome and pregnancy rates.
METHODS: Each locus was studied alone, and in combination with the others. We performed both restriction fragment length polymorphism analysis and real-time polymerase chain reaction. A total of 109 normally ovulating female patients underwent IVF or ICSI.
RESULTS: Studying each locus alone, no significant results were drawn for ESR1 and ESR2 genes. Concerning the FSHR polymorphism, the women carrying the AA variant presented higher total amount of gonadotrophins used (P=0,048) and tended to have higher number of stimulation days (P=0,057). Considering the ESR1 and FSHR gene polymorphisms in combination, the TC/SA combination presents the highest number of pregnancies in poor responders group (3/4 pregnancies carried this genotype), in good responders group (4/12 pregnancies carried this genotype) and in the total population (10/26 pregnancies carried this genotype). Except the CC/AA combination, all other genotype combinations presented incidence of pregnancy, with TC/SA having the highest incidence. The CC/AA genotype presents the worst profile of ovulation induction, confirming a poor responder profile: the total amount of gonadotrophins used was highest in CC/AA group (P < 0,05). The peak E2, the number of follicles and of retrieved oocytes and the pregnancy rate were significantly lower (P < 0,05). This genotype combination seems to be over-presented in the poor responders group in a statistically significant way (P=0,038). Women with CC/AA combination have 1,5-2,4 times more risk to be poor responders in comparison with women that do not carry that combination.
CONCLUSION: This study supports the hypothesis that a multigenic model, including the well studied ESR1 and FSHR genes is involved in the controlled ovarian stimulation outcome indicating that the CC/AA genotype presents the worst ovulation induction profile, while the TC/SA genotype presents the higher number of pregnancies in our population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21658000     DOI: 10.2174/138920112799361891

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  13 in total

1.  Oocyte retrieval outcomes among adolescent transgender males.

Authors:  Hadar Amir; Asaf Oren; Emilie Klochendler Frishman; Onit Sapir; Yoel Shufaro; Anat Segev Becker; Foad Azem; Avi Ben-Haroush
Journal:  J Assist Reprod Genet       Date:  2020-05-20       Impact factor: 3.412

2.  Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.

Authors:  Iro Karagiorga; George A Partsinevelos; Despina Mavrogianni; Elli Anagnostou; Ioannis Zervomanolakis; Konstantinos Kallianidis; Petros Drakakis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2014-12-27       Impact factor: 3.412

3.  An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review.

Authors:  B S Eisele; G C Villalba Silva; C Bessow; R Donato; V K Genro; J S Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2021-03-31       Impact factor: 3.357

4.  Comparison of the Fetal Fraction of Cell-Free DNA in In-Vitro Fertilization (IVF) Versus Natural Conception Evaluation of the Fetal Fraction With IVF Parameters.

Authors:  Kostas Kallianidis; Evangelia Dimitroulia; Depy Mavrogianni; Emmanuaela Liokari; Ritsa Bletsa; Elli Anagnostou; Nikos Sofikitis; Dimitrios Loutradis
Journal:  Cureus       Date:  2022-04-26

5.  Do estrogen receptor alpha polymorphisms have any impact on the outcome in an ART program?

Authors:  Elli Anagnostou; Fotodotis Malamas; Despina Mavrogianni; Vasiliki Dinopoulou; Peter Drakakis; Konstantinos Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2013-03-15       Impact factor: 3.412

6.  Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI.

Authors:  Radia Boudjenah; Denise Molina-Gomes; Antoine Torre; Marianne Bergere; Marc Bailly; Florence Boitrelle; Stéphane Taieb; Robert Wainer; Mohamed Benahmed; Philippe de Mazancourt; Jacqueline Selva; François Vialard
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

7.  ESR1 and ESR2 gene polymorphisms are associated with human reproduction outcomes in Brazilian women.

Authors:  Clarissa Santiago de Mattos; Camila Martins Trevisan; Carla Peluso; Fernando Adami; Emerson Barchi Cordts; Denise Maria Christofolini; Caio Parente Barbosa; Bianca Bianco
Journal:  J Ovarian Res       Date:  2014-12-20       Impact factor: 4.234

8.  Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.

Authors:  Travis J O'Brien; Mariah M Kalmin; Arthur F Harralson; Adam M Clark; Ian Gindoff; Samuel J Simmens; David Frankfurter; Paul Gindoff
Journal:  Reprod Biol Endocrinol       Date:  2013-07-25       Impact factor: 5.211

9.  ESR1 rs9340799 is associated with endometriosis-related infertility and in vitro fertilization failure.

Authors:  Diego Davila Paskulin; João Sabino Cunha-Filho; Livia Davila Paskulin; Carlos Augusto Bastos Souza; Patricia Ashton-Prolla
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434

10.  Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry.

Authors:  Gabriela García-Jiménez; Teresa Zariñán; Rocío Rodríguez-Valentín; Nancy R Mejía-Domínguez; Rubén Gutiérrez-Sagal; Georgina Hernández-Montes; Armando Tovar; Fabián Arechavaleta-Velasco; Patricia Canto; Julio Granados; Hortensia Moreno-Macias; Teresa Tusié-Luna; Antonio Pellicer; Alfredo Ulloa-Aguirre
Journal:  Reprod Biol Endocrinol       Date:  2018-10-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.